• Psychogenic stress-dependent disorders of menstrual cycle: role of non-hormonal correction
Come back

Psychogenic stress-dependent disorders of menstrual cycle: role of non-hormonal correction

HEALTH OF WOMAN. 2018.10(136):68–72
Kuznetsova I. V., Burchakova M. N. , Burchakov D. I. , Khadzhieva N. Kh. , Filippova G. G.
FSBEI of HE «First Moscow State Medical University named after I.M. Sechenov» Ministry of Health of Russia, Moscow
ANO VO «Moscow University of the Humanities», Moscow

Published: Medical Alphabet № 10/2017, volume No. 2 «Modern gynecology»

Menstrual disorders are widespread in the population, a significant part of them is associated with stress. However, stress is not identical simply to nervous tension, it is a nonspecific reaction to changes in conditions that require adaptation. Stress factors should be divided into physical, metabolic and psychological factors. Of particular importance are violations of the biological rhythms of the body, as well as psychological features of the relationship of patients with the mother. in general, with expressed stress, the reproductive function is inhibited. This effect is realized in several ways, in particular through transient hyperprolactinemia. Treatment of functional, stress-depen­dent hyperprolactinemia is carried out by plant dopaminomimetics. The use of Vitex agnus-castus drugs in such patients normalizes the secretion of prolactin and regulates the menstrual cycle.

Key words: stress, adaptation, menstrual cycle disorders, oligo­menorrhea, transient hyperprolactinemia, Vitex agnus-castus.

REFERENCES

1. Adilhanova AH. 2011. Mediko-sotsialnyie predposyilki stanovleniya reproduktivnoy sistemyi u devochek-podrostkov iz neblagopoluchnyih semey. Avtoref. diss. kand. med. nauk. Sankt-Peterburg.

2. Gorelyishev A, Kuznetsova I. 2015. Menstrualnyiy tsikl i energeticheskaya «politika» gipotalamusa. Effektivnaya farmakoterapiya 5:4-12.

3. Fillipova G. 2003. Narusheniya reproduktivnoy funktsii i ee svyaz s narusheniyami v formirovanii materinskoy sferyi. Zhurnal prakticheskogo psihologa 4-5:83-109.

4. Kubasov R. 2014. Funktsionalnyie izmeneniya gipofizarno-gonadnogo i tireoidnogo endokrinnyih zvenev v otvet na stressovyie faktory. Fundamentalnyie issledovaniya 10:1010-4.

5. Tworoger SS, Eliassen AH, Zhang X, Qian J, Sluss PM, Rosner BA et al. (2013). A 20-year prospective study of plasma prolactin as a risk marker of breast cancer development. Cancer Res. 73:4810-9. doi:10.1158/0008-5472.CAN-13-0665.

6. McHale K, Tomaszewski JE, Puthiyaveettil R, LiVolsi VA, Clevenger CV. 2008. Altered expression of prolactin receptor-associated signaling proteins in human breast carcinoma. Mod. Pathol. 21:565-71. doi:10.1038/ modpathol.2008.7.

7. Freeman EW. 2010. Therapeutic management of premenstrual syndrome. Expert Opin. Pharmacother. 11:2879-89. doi:10.1 517/14656566.2010.509344.

8. Biason TP, Goldberg TBL, Kurokawa CS, Moretto MR, Teixeira AS, Nunes HR de C. 2015. Low-dose combined oral contraceptive use is associated with lower bone mineral content variation in adolescents over a 1-year period. BMC Endocr. Disord. 15:15. doi:10.1186/s12902-015-0012-7.

9. Simonovskaya H. 2012. Fitoterapiya: zelenyie perspektivyi. Intervyu s predsedatelem soveta direktorov kompanii «Bionorika» prof. Mihaelem Poppom. Status Praesens 5:39-45.

10. Vuttke V, Zaydlova-Vuttke D, Yarri G, Artyimuk N. 2014. Rol Viteksa svyaschennogo (Vitex agnus castus) v ginekologicheskoy endokrinologii. Ginekologiya 1:4-7.

11. Wuttke W, Seidlova-Wuttke D, Jarry H, Artymuk N. 2010. Der Stelenwert des Monchspfeffer (Vitex agnus-castus). Zeitschrift Fur Phyther. 31:294-8.

12. Artyimuk N, Ustinova T, Vlasova V. 2011. Opyit primeneniya Vitex Agnus Castus v komplekse lecheniya patsientok s sindromom polikistoznyih yaichnikov i besplodiem. Rossiyskiy vestnik akushera-ginekologa 2:65-8.

13. Tsoy L. 2010. Lekarstvennaya terapiya diffuznoy mastopatii i PMS. Onkologiya, gematologiya i radiologiya 3:2-7.

14. Elsayed M. 2013. Agnucaston and Clomiphen Citrate in Infertile Patients with Polycystic Ovaries. J. Fertil. Vitr. IVF-Worldwide, Reprod. Med. Genitics Stem Cell Biol. 2:33-40. doi:10.4172/2375-4508.1000108.

15. Khalilzadeh E, Vafaei Saiah G, Hasannejad H, Ghaderi A, Ghaderi S, Hamidian G et al. Antinociceptive effects, acute toxicity and chemical composition of Vitex agnus-castus essential oil. Avicenna J. Phytomedicine n.d.; 5: 218-30.

16. Ma L, Lin S, Chen R, Zhang Y, Chen F, Wang X. 2010. Evaluating therapeutic effect in symptoms of moderate-to-severe premenstrual syndrome with Vitex agnus castus (BNO 1095) in Chinese women. Aust New Zeal. J. Obstet. Gynaecol. 50:189-93. doi:10.1111/j.1479-828X.2010.01137.x.

17. Zamani M, Neghab N, Torabian S. 2012. Therapeutic effect of Vitex agnus castus in patients with premenstrual syndrome. Acta Med. Iran 50:101-6.

18. Van Die M, Burger H, Teede H, Bone K. 2012. Vitex agnus-castus Extracts for Female Reproductive Disorders: A Systematic Review of Clinical Trials. Planta Med. 79:562-75. doi:10.1055/s-0032-1327831.

19. Arentz S, Abbott JA, Smith CA, Bensoussan A. 2014. Herbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo/amenorrhoea and hyperandrogenism; a review of the laboratory evidence for effects with corroborative clinical findings. BMC Complement. Altern. Med. 14:511. doi:10.1186/1472-6882-14-511.

20. Shahin AY, Mohammed SA. 2014. Adding the phytoestrogen Cimicifugae Racemosae to clomiphene induction cycles with timed intercourse in polycystic ovary syndrome improves cycle outcomes and pregnancy rates – a randomized trial. Gynecol. Endocrinol. 30:505-10. doi:10.3109/095135 90.2014.895983.

21. Kamel HH. 2013. Role of phyto-oestrogens in ovulation induction in women with polycystic ovarian syndrome. Eur. J. Obstet. Gynecol. Reprod. Biol. 168:60-3. doi:10.1016/j. ejogrb.2012.12.025.

22. Kuznetsova I, Uspenskaya Yu, Dil V, Grineva A. 2015. Ispolzovanie rastitelnyih dofaminomimetikov u podrostkov i molodyih zhenschin s narushennyim menstrualnyim tsiklom. Akusherstvo i ginekologiya 10:1-8.